FDA anuncia o fim da escassez de Wegovy e Ozempic; farmácias compostas devem parar substitutos. FDA announces end to shortage of Wegovy and Ozempic; compounding pharmacies must stop substitutes.

A FDA anunciou o fim da escassez nacional de medicamentos para perda de peso e diabetes da Novo Nordisk, Wegovy e Ozempic. The FDA has announced the end of the nationwide shortage of Novo Nordisk's weight-loss and diabetes drugs, Wegovy and Ozempic. A empresa aumentou a produção e investiu bilhões para atender à demanda. The company increased production and invested billions to meet demand. Farmácias de compostos, que têm vindo a fazer alternativas mais baratas, deve parar de produzir esses substitutos dentro de 60 a 90 dias. Compounding pharmacies, which have been making cheaper alternatives, must stop producing these substitutes within 60 to 90 days.